Certara (NASDAQ:CERT) Shares Gap Up – Should You Buy?

Certara, Inc. (NASDAQ:CERT)’s stock price gapped up before the market opened on Thursday . The stock had previously closed at $12.33, but opened at $13.08. Certara shares last traded at $12.41, with a volume of 191,824 shares traded.

Analyst Upgrades and Downgrades

CERT has been the subject of a number of research reports. Stephens reiterated an “overweight” rating and set a $17.00 price objective on shares of Certara in a report on Thursday. Robert W. Baird decreased their price objective on Certara from $18.00 to $13.00 and set a “neutral” rating for the company in a report on Tuesday, November 5th. William Blair reiterated a “market perform” rating on shares of Certara in a report on Thursday. TD Cowen initiated coverage on Certara in a report on Thursday. They set a “buy” rating and a $16.00 price objective for the company. Finally, Barclays increased their price objective on Certara from $12.00 to $13.00 and gave the stock an “equal weight” rating in a report on Friday. Five investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $15.79.

Certara Stock Performance

The company has a quick ratio of 2.86, a current ratio of 2.86 and a debt-to-equity ratio of 0.28. The stock has a 50 day simple moving average of $12.45 and a two-hundred day simple moving average of $11.64. The stock has a market capitalization of $1.93 billion, a P/E ratio of -59.90, a P/E/G ratio of 9.29 and a beta of 1.57.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the stock. Brown Brothers Harriman & Co. bought a new position in shares of Certara during the 3rd quarter worth approximately $27,292,000. Kopion Asset Management LLC boosted its stake in shares of Certara by 46.0% during the 4th quarter. Kopion Asset Management LLC now owns 555,643 shares of the company’s stock worth $5,918,000 after acquiring an additional 175,005 shares during the period. Massachusetts Financial Services Co. MA boosted its stake in shares of Certara by 40.7% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,901,898 shares of the company’s stock worth $45,691,000 after acquiring an additional 1,128,006 shares during the period. Vontobel Holding Ltd. bought a new position in shares of Certara during the 4th quarter worth approximately $1,295,000. Finally, Barclays PLC boosted its stake in shares of Certara by 198.3% during the 3rd quarter. Barclays PLC now owns 70,525 shares of the company’s stock worth $825,000 after acquiring an additional 46,880 shares during the period. 73.96% of the stock is currently owned by institutional investors.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.